I am most definitely in it. I don't know if there are any gems in the sense that everyone knows about stocks they're buying, but I'm a fan of hmc, adi, and nflx- and I like a lot of the stem cell companies, which go up every time the dems win elections, so next year they should do really well. Specifically, I like Gern, Stem, Cytx, and especially Astm. Astm has a product with the potential for speeding up recovery from broken bones, which would be huge if it became part of the standard of care. Obviously it's super risky, but it's also super cheap. Gern has a similar product, but it's 6-7 times more expensive.</p> Adi I like because they make motion capture chips - like those in the Nintendo Wii controls - which I think is an expanding market. But it's gone down since I bought it. They're selling off product lines which I can't tell if it's a good thing or a bad thing.</p> Also look at dsco- poorly run company, but they're about to find out from the fda if they finally meet its requirements, which would obviously give it a huge boost. They seem to have a decent drug that had issues with being stable enough to be sold, but they claim to have resolved that.</p> </p>
<div class='quotetop'>QUOTE (lukewarmplay)</div><div class='quotemain'></p> I am most definitely in it. I don't know if there are any gems in the sense that everyone knows about stocks they're buying, but I'm a fan of hmc, adi, and nflx- and I like a lot of the stem cell companies, which go up every time the dems win elections, so next year they should do really well. Specifically, I like Gern, Stem, Cytx, and especially Astm. Astm has a product with the potential for speeding up recovery from broken bones, which would be huge if it became part of the standard of care. Obviously it's super risky, but it's also super cheap. Gern has a similar product, but it's 6-7 times more expensive.</p> Adi I like because they make motion capture chips - like those in the Nintendo Wii controls - which I think is an expanding market. But it's gone down since I bought it. They're selling off product lines which I can't tell if it's a good thing or a bad thing.</p> Also look at dsco- poorly run company, but they're about to find out from the fda if they finally meet its requirements, which would obviously give it a huge boost. They seem to have a decent drug that had issues with being stable enough to be sold, but they claim to have resolved that.</p> </p> </div></p> Don't think NFLX will face any growth in the future. I'm afraid they have reached their "carrying capacity". And i was in ASTM but this pos dissappoints. The thing with stem cell companies - they can be flat for years until they announce positive results of some study and then they jump 100% in a minute... I'm not patient enough to be in one stock for years.</p> My choice: GIGM, BIDU, AAPL, BRCM, GRMN - techs</p> PKX - steel, DLB - equipment, HK - oil</p> </p>
<div class='quotetop'>QUOTE (Belarus)</div><div class='quotemain'></p> <div class='quotetop'>QUOTE (lukewarmplay)</div><div class='quotemain'></p> I am most definitely in it. I don't know if there are any gems in the sense that everyone knows about stocks they're buying, but I'm a fan of hmc, adi, and nflx- and I like a lot of the stem cell companies, which go up every time the dems win elections, so next year they should do really well. Specifically, I like Gern, Stem, Cytx, and especially Astm. Astm has a product with the potential for speeding up recovery from broken bones, which would be huge if it became part of the standard of care. Obviously it's super risky, but it's also super cheap. Gern has a similar product, but it's 6-7 times more expensive.</p> Adi I like because they make motion capture chips - like those in the Nintendo Wii controls - which I think is an expanding market. But it's gone down since I bought it. They're selling off product lines which I can't tell if it's a good thing or a bad thing.</p> Also look at dsco- poorly run company, but they're about to find out from the fda if they finally meet its requirements, which would obviously give it a huge boost. They seem to have a decent drug that had issues with being stable enough to be sold, but they claim to have resolved that.</p> </p> </div></p> Don't think NFLX will face any growth in the future. I'm afraid they have reached their "carrying capacity". And i was in ASTM but this pos dissappoints. The thing with stem cell companies - they can be flat for years until they announce positive results of some study and then they jump 100% in a minute... I'm not patient enough to be in one stock for years.</p> My choice: GIGM, BIDU, AAPL, BRCM, GRMN - techs</p> PKX - steel, DLB - equipment, HK - oil</p> </div></p> Over and over, that's the way that's shown to provide the largest returns.</p> </p> </p>
I should add this about Netflix: I'm already using their Watch Now feature more than I do the DVD's by mail, and I'm using it to watch TV shows that I've missed. You don't think broadband TV is a growth market and that Netflix has as good a chance as anyone to capture a portion of it? That would be a valid opinion, but the opportunity is certainly there.</p>